Durvalumab +/- tremelimumab plus platinum-etoposide in first-line (1L) extensive-stage SCLC (ES-SCLC): Results from the phase 3 CASPIAN study

Grohe C., Paz-Ares L. G., Dvorkin M., Chen Y., Hotta K., Trukhin D., ...More

ONCOLOGY RESEARCH AND TREATMENT, vol.43, pp.149, 2020 (SCI-Expanded)

  • Publication Type: Article / Abstract
  • Volume: 43
  • Publication Date: 2020
  • Journal Name: ONCOLOGY RESEARCH AND TREATMENT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
  • Page Numbers: pp.149
  • Istanbul University Affiliated: No